Seeking Alpha - Synergy Pharma makes sweet deal with debt holders Nov. 21, 2016 8:20 PM• SA Editor Douglas W. House Synergy Pharmaceuticals (NASDAQ:SGYP) inks exchange agreements with certain holders of its 7.5% Convertible Senior Notes due 2019 under which an aggregate principal amount of ~$20.7M of the Notes and accrued but unpaid interest was exchanged for 7,555,683 shares of common stock which equates $2.74 per common share.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.